rewirebio.iobenchmarks
Evidence claim

Relevance of ucc-research-protocol-foldbench-antibody-antigen to "Which predicted interfaces or structures are reliable enough to guide my next experiment?"

Use case
Choose structural hypotheses to guide experiments
Assessed by
FoldBench antibody-antigen published full-set assessment
Relevance
Proxy evidence
Endpoint
FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries

The only multi-tool comparison stored for antibody-antigen complexes on a held-out set with five current cofolding tools under one protocol. It is proxy evidence: success means structural agreement with the deposited complex, and confidence is not assessed.

5 reviewed evaluations

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

40 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    ucc-research-source-foldbench-supp
    locator
    Supplementary Table 3, antibody-antigen block
  • source id
    ucc-research-source-foldbench-paper
    locator
    Table 1 assessable counts
Context-only references
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    ucc-research-source-foldbench-supp
    locator
    Supplementary Table 3, antibody-antigen block
  • source id
    ucc-research-source-foldbench-paper
    locator
    Table 1 assessable counts
Context-only references
FoldBench supplementary target coverage and performance

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
antibody-antigen-interfaces
Context-only references
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
antibody-antigen-interfaces
Context-only references
FoldBench supplementary target coverage and performance

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
Antibody-antigen interface predictions
Context-only references
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
Antibody-antigen interface predictions
Context-only references
FoldBench supplementary target coverage and performance

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
4 values
  • Inspect every linked evaluation's source locator and preserved limitations before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results; complex sets, sampling and metrics differ.
  • Results for one complex class do not establish performance in another.
  • Structural accuracy and confidence are not evidence that an interaction exists, how strong it is or that an experiment will work.
Context-only references
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
4 values
  • Inspect every linked evaluation's source locator and preserved limitations before citing a result.
  • Do not combine this mapping's evaluations with any other protocol's results; complex sets, sampling and metrics differ.
  • Results for one complex class do not establish performance in another.
  • Structural accuracy and confidence are not evidence that an interaction exists, how strong it is or that an experiment will work.
Context-only references
FoldBench supplementary target coverage and performance

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries
Context-only references
Benchmarking all-atom biomolecular structure prediction with FoldBench

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:23:29Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 3104bc7a0c5dd138421edfae72008fe1369b18192702fb7474a2517aece31928

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries
Context-only references
FoldBench supplementary target coverage and performance

Original source ↗

ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Supplementary Information to 10.1038/s41467-025-67127-3
Retrieved: 2026-09-30T21:26:52Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: c699bd6b7ef8277ce4f89d12ff2365cd7a199dbc7eb4b674aeba4e62da92d5bb

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-structural-20261009-foldbench-antibody-antigen

field
links:assessed_by:ucc-research-protocol-foldbench-antibody-antigen
value
ucc-research-protocol-foldbench-antibody-antigen
relevance
proxy
endpoint
FoldBench success rate, LDDT, interface RMSD and ligand RMSD for AlphaFold 3, Boltz-1, Chai-1, HelixFold 3 and Protenix on antibody-antigen targets with low homology to earlier PDB entries
rationale
The only multi-tool comparison stored for antibody-antigen complexes on a held-out set with five current cofolding tools under one protocol. It is proxy evidence: success means structural agreement with the deposited complex, and confidence is not assessed.
constraints
Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; complex sets, sampling and metrics differ.; Results for one complex class do not establish performance in another.; Structural accuracy and confidence are not evidence that an interaction exists, how strong it is or that an experiment will work.
limitations
Benchmark authors ran all five tools; per-tool assessable counts differ, so the scored populations are not matched.; Structural success against the deposited complex, not binding, affinity or the outcome of an experiment.; No uncertainty is printed.; Antibody-antigen targets only.; The mapped evaluations are stored records reviewed in an earlier batch; this review checked their status, their links and their fit, not their values against FoldBench.
citation locators
source id: ucc-research-source-foldbench-supp; locator: Supplementary Table 3, antibody-antigen block; source id: ucc-research-source-foldbench-paper; locator: Table 1 assessable counts
source locator
ucc-research-source-foldbench-supp: Supplementary Table 3, antibody-antigen block; ucc-research-source-foldbench-paper: Table 1 assessable counts
revision
1
reason
Add comparisons of structure-prediction reliability by complex class from the structural hypotheses use-case pass 2026-10-09.
comparison group
antibody-antigen-interfaces
comparison title
Antibody-antigen interface predictions
headline metric
foldbench-success-rate
stratum label
Accuracy of five tools (FoldBench)
stratum order
1
reviewed evaluations
ucc-research-eval-foldbench-antibody-antigen-af3; ucc-research-eval-foldbench-antibody-antigen-boltz1; ucc-research-eval-foldbench-antibody-antigen-chai1; ucc-research-eval-foldbench-antibody-antigen-helixfold3; ucc-research-eval-foldbench-antibody-antigen-protenix
review
method: automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; reviewed at: 2026-10-10T00:30:00Z; note: Independent review of endpoint fit, relevance grade, limitations, exclusions and grouping against the use case. The mapped evaluations and their results are already source_checked in the store and were not re-extracted here; their FoldBench values were reviewed in the batch that added them. No execution, reproduction, human scientific review or clinical validation.
pins
record id: ucc-research-eval-foldbench-antibody-antigen-af3; fields: status; links; attributes.origin; attributes.comparison; sha256: 54d2bed125c2af8cea77efb5c9d2531423622beace308b59c0b86c0ae619e60b; record id: ucc-research-eval-foldbench-antibody-antigen-boltz1; fields: status; links; attributes.origin; attributes.comparison; sha256: 3ba375ca1ffb0e5286d5b2f31a89e21388c8bad4675bb567963820dcbeaa2e8d; record id: ucc-research-eval-foldbench-antibody-antigen-chai1; fields: status; links; attributes.origin; attributes.comparison; sha256: 91917466e3b1c209230c815382bafd238c85b72bcdcd0495ad642085aeaa0da2; record id: ucc-research-eval-foldbench-antibody-antigen-helixfold3; fields: status; links; attributes.origin; attributes.comparison; sha256: 9d4eaa21a5cd25a2d51f52a3c334ba298cbe46e019222f4d8e5b6adb6720e2ba; record id: ucc-research-eval-foldbench-antibody-antigen-protenix; fields: status; links; attributes.origin; attributes.comparison; sha256: f5d37644b7d53ac4ef5b713d50a40ba35bc66dc647df12f3ea5b5a507cb0cbea; record id: ucc-research-protocol-foldbench-antibody-antigen; fields: status; name; description; facets; source_ids; links; attributes; sha256: 91a123584b1c7f25c9f447435c0e87bef7fe365fe4e68be1410c8f9f4aef2a97; record id: ucc-research-result-foldbench-antibody-antigen-af3-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d4c3da6fe3d5aea2f2387e4eb31c20286ab1cf8f310b20a833cafc36f5a01b0e; record id: ucc-research-result-foldbench-antibody-antigen-af3-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 1815a7850b084d619237261e32c3c6d1d40b21c25f9d1e2c0ab4ec9668b10e7e; record id: ucc-research-result-foldbench-antibody-antigen-af3-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: b67235e6a720e20fcc86405f3ec953e380e224725974a0f8fbe4c6e51ab7416d; record id: ucc-research-result-foldbench-antibody-antigen-af3-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 98b37dd98221d934f93be13514d8ca59c22ccf44dbe67e258ac3aff34ac73d2c; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: cb2dc2ecb32bb570697b5b9a291d775c00834cbcf3c16d285d44024f901b3512; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3e16f64f4f094f989f39fc8ed53b06ac1094da0a2d9b43bc557c0328a06f736d; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8e1653045021358ced401d1bdab5d8387a180899476a5434db8f49e9e111f028; record id: ucc-research-result-foldbench-antibody-antigen-boltz1-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: da13210c68200f578dbe5625ecefc4e7b8eff0c837119a4135012c24aee9de91; record id: ucc-research-result-foldbench-antibody-antigen-chai1-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: f6df3023c26d4c2f7b178d12bf3b13e5cb6ff1029c2d59124b003fef30ab0320; record id: ucc-research-result-foldbench-antibody-antigen-chai1-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d769e4809a3bf5af504b1d5874caf550af637cdc89093786d21f0754c8b20288; record id: ucc-research-result-foldbench-antibody-antigen-chai1-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8dd92674d074c7240be4dd42c7c7123487e2b9d51c61a9f42df6f5cbf6cec9d1; record id: ucc-research-result-foldbench-antibody-antigen-chai1-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 9cb873e508c6b96a7e2d474774b1b2094f2e7ffbbe27f05b4091297e06686889; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: aa52c743c0f011ffb11a9ab2f43cb17870ef881296add0843e4fb5a4921ed80d; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3e16f64f4f094f989f39fc8ed53b06ac1094da0a2d9b43bc557c0328a06f736d; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8cc5f117edf2dd514a3f4697b7ae7d513a3727c46310bf08447a533036e1e8be; record id: ucc-research-result-foldbench-antibody-antigen-helixfold3-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: aef895a81e9f64dc83e0c9fcf1b6bae0d0b608793b586a3143a396c8dc66c6de; record id: ucc-research-result-foldbench-antibody-antigen-protenix-irmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 7e99b58fe7541fb4dbe721c7db5c53a2dc2b8c0e8bf03a218075b07195d66215; record id: ucc-research-result-foldbench-antibody-antigen-protenix-lddt; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: d769e4809a3bf5af504b1d5874caf550af637cdc89093786d21f0754c8b20288; record id: ucc-research-result-foldbench-antibody-antigen-protenix-lrmsd; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 65a617cbb7b631e8e1e8660713c7dd9585e8d7c0078df17fc662c8f9ea2b42ef; record id: ucc-research-result-foldbench-antibody-antigen-protenix-success-rate; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 675b91a6ddf32cf262c3cb2778df71c984dfb014f679c195edd65837989d6f4e; record id: ucc-research-source-foldbench-code; fields: status; attributes.artifact_sha256; sha256: b97ab3e3cd7f20ced10d92de2e33fdb7f3beb8e3b3f107101ecfdb289eb7b60c; record id: ucc-research-source-foldbench-paper; fields: status; attributes.artifact_sha256; sha256: 5223745a7869c987d6285239b14b39e9673f01a9e4f51721ee51bb3573bd2c0d; record id: ucc-research-source-foldbench-supp; fields: status; attributes.artifact_sha256; sha256: 676f28c7775d7f6a7ca7fc28f4407a8a13fd6f6d7854d7743cec93dc082d72b1; record id: use-case-structural-hypotheses-experiments; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 323c287cae7885e983feb5d58f24115afe49ecfbb868a0238c75b1247ffcf228
Related records

Suggest a correction